Vasopressin and Nirmatrelvir/Ritonavir Interaction

Drug interaction information between Vasopressin and Nirmatrelvir/Ritonavir.

Vasopressin and Nirmatrelvir/Ritonavir have a documented major interaction in FDA labeling.

FDA drug labeling documents a major-severity interaction between Vasopressin and Nirmatrelvir/Ritonavir. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Vasopressin

Vasopressin Receptor Agonist

Drug B

Nirmatrelvir/Ritonavir

Antiviral (Protease Inhibitor Combination)

How They Interact

This combination causes tolvaptan levels to rise because the body cannot get rid of it fast enough. This can lead to severe fluid loss and high potassium levels.

FDA Label Information

Vasopressin receptor antagonists tolvaptan ↑ tolvaptan Co-administration contraindicated due to potential for dehydration, hypovolemia and hyperkalemia [see Contraindications (4) ] .

Frequently Asked Questions

What SPL severity band is on file for Vasopressin + Nirmatrelvir/Ritonavir?

Compiled FDA labeling labels this pair major. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Nirmatrelvir/Ritonavir has 86 labeled pairs on file vs Vasopressin's 9. In the major band specifically: Vasopressin has 1; Nirmatrelvir/Ritonavir has 23 (also Simvastatin, Lovastatin, Sildenafil, Carbamazepine).

What mechanism field is on file for Vasopressin and Nirmatrelvir/Ritonavir?

This combination causes tolvaptan levels to rise because the body cannot get rid of it fast enough. This can lead to severe fluid loss and high potassium levels.

Nirmatrelvir/Ritonavir carries more major-labeled pairs than Vasopressin

SPL source-record counts only. This page's band is major · classes on file: Vasopressin (Vasopressin Receptor Agonist); Nirmatrelvir/Ritonavir (Antiviral (Protease Inhibitor Combination)).

Nirmatrelvir/Ritonavir has 23 major-labeled pairs vs Vasopressin's 1.

Vasopressin

1 major · 1 moderate · 7 minor · 9 total

Vasopressin has no other major-band peer in this dataset besides Nirmatrelvir/Ritonavir.

Nirmatrelvir/Ritonavir

23 major · 30 moderate · 33 minor · 86 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.